1. Bortezomib, thalidomide and dexamethasone, with or without cyclophosphamide, for patients with previously untreated multiple myeloma: 5‐year follow‐up. (7th July 2015) Authors: Ludwig, Heinz; Greil, Richard; Masszi, Tamas; Spicka, Ivan; Shpilberg, Ofer; Hajek, Roman; Dmoszynska, Anna; Paiva, Bruno; Vidriales, María‐Belén; Esteves, Graca; Stoppa, Anne Marie; Robinson, Don; Chaturvedi, Shalini; Ataman, Ozlem; Enny, Christopher; Feng, Huaibao; van de Velde, Helgi; Viterbo,... Journal: British journal of haematology Issue: Volume 171:Number 3(2015:Nov.) Page Start: 344 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Chromosomal 1q21 abnormalities in multiple myeloma: a review of translational, clinical research, and therapeutic strategies. Issue 12 (2nd December 2021) Authors: Bisht, Kamlesh; Walker, Brian; Kumar, Shaji K.; Spicka, Ivan; Moreau, Philippe; Martin, Tom; Costa, Luciano J.; Richter, Joshua; Fukao, Taro; Macé, Sandrine; van de Velde, Helgi Journal: Expert review of hematology Issue: Volume 14:Issue 12(2021) Page Start: 1099 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Combined treatment of primary vitreoretinal lymphomas significantly prolongs the time to first relapse. Issue 11 (29th January 2018) Authors: Klimova, Aneta; Heissigerova, Jarmila; Rihova, Eva; Brichova, Michaela; Pytlik, Robert; Spicka, Ivan; Mrazova, Katerina; Karolova, Jana; Svozilkova, Petra Journal: British journal of ophthalmology Issue: Volume 102:Issue 11(2018) Page Start: 1579 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Development and validation of a novel risk stratification algorithm for relapsed multiple myeloma. (6th August 2019) Authors: Hájek, Roman; Delforge, Michel; Raab, Marc S.; Schoen, Paul; DeCosta, Lucy; Spicka, Ivan; Radocha, Jakub; Pour, Ludek; Gonzalez‐McQuire, Sebastian; Bouwmeester, Walter Journal: British journal of haematology Issue: Volume 187:Number 4(2019) Page Start: 447 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Effect of age and frailty on the efficacy and tolerability of once‐weekly selinexor, bortezomib, and dexamethasone in previously treated multiple myeloma. Issue 6 (3rd May 2021) Authors: Auner, Holger W.; Gavriatopoulou, Maria; Delimpasi, Sosana; Simonova, Maryana; Spicka, Ivan; Pour, Ludek; Dimopoulos, Meletios A.; Kriachok, Iryna; Pylypenko, Halyna; Leleu, Xavier; Doronin, Vadim; Usenko, Ganna; Hajek, Roman; Benjamin, Reuben; Dolai, Tuphan Kanti; Sinha, Dinesh Kumar; Venner, Ch... Journal: American journal of hematology Issue: Volume 96:Issue 6(2021) Page Start: 708 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Efficacy and safety of oral panobinostat plus subcutaneous bortezomib and oral dexamethasone in patients with relapsed or relapsed and refractory multiple myeloma (PANORAMA 3): an open-label, randomised, phase 2 study. Issue 1 (January 2021) Authors: Laubach, Jacob P; Schjesvold, Fredrik; Mariz, Mário; Dimopoulos, Meletios A; Lech-Maranda, Ewa; Spicka, Ivan; Hungria, Vania T M; Shelekhova, Tatiana; Abdo, Andre; Jacobasch, Lutz; Polprasert, Chantana; Hájek, Roman; Illés, Árpád; Wróbel, Tomasz; Sureda, Anna; Beksac, Meral; Gonçalves, Iara Z; Bl... Journal: Lancet oncology Issue: Volume 22:Issue 1(2021) Page Start: 142 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Elotuzumab plus lenalidomide/dexamethasone for relapsed or refractory multiple myeloma: ELOQUENT‐2 follow‐up and post‐hoc analyses on progression‐free survival and tumour growth. (5th July 2017) Authors: Dimopoulos, Meletios A.; Lonial, Sagar; White, Darrell; Moreau, Philippe; Palumbo, Antonio; San‐Miguel, Jesus; Shpilberg, Ofer; Anderson, Kenneth; Grosicki, Sebastian; Spicka, Ivan; Walter‐Croneck, Adam; Magen, Hila; Mateos, Maria‐Victoria; Belch, Andrew; Reece, Donna; Beksac, Meral; Bleickardt, ... Journal: British journal of haematology Issue: Volume 178:Number 6(2017) Page Start: 896 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Evaluation of isatuximab in patients with soft-tissue plasmacytomas: An analysis from ICARIA-MM and IKEMA. (November 2022) Authors: Beksac, Meral; Spicka, Ivan; Hajek, Roman; Bringhen, Sara; Jelínek, Tomas; Martin, Thomas; Mikala, Gabor; Moreau, Philippe; Symeonidis, Argiris; Rawlings, Andreea M.; van de Velde, Helgi; Richardson, Paul G. Journal: Leukemia research Issue: Volume 122(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Final overall survival results of a randomized trial comparing bortezomib plus pegylated liposomal doxorubicin with bortezomib alone in patients with relapsed or refractory multiple myeloma. Issue 13 (18th May 2016) Authors: Orlowski, Robert Z.; Nagler, Arnon; Sonneveld, Pieter; Bladé, Joan; Hajek, Roman; Spencer, Andrew; Robak, Tadeusz; Dmoszynska, Anna; Horvath, Noemi; Spicka, Ivan; Sutherland, Heather J.; Suvorov, Alexander N.; Xiu, Liang; Cakana, Andrew; Parekh, Trilok; San‐Miguel, Jesús F. Journal: Cancer Issue: Volume 122:Issue 13(2016) Page Start: 2050 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Health‐related quality of life maintained over time in patients with relapsed or refractory multiple myeloma treated with daratumumab in combination with bortezomib and dexamethasone: results from the phase III CASTOR trial. (8th February 2021) Authors: Hungria, Vania; Beksac, Meral; Weisel, Katja C.; Nooka, Ajay K.; Masszi, Tamas; Spicka, Ivan; Munder, Markus; Mateos, María‐Victoria; Mark, Tomer M.; Qi, Ming; Qin, Xiang; Fastenau, John; Spencer, Andrew; Sonneveld, Pieter; Garvin, Wendy; Renaud, Thomas; Gries, Katharine S. Journal: British journal of haematology Issue: Volume 193:Number 3(2021) Page Start: 561 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗